XIENCE ALPINE Trademark

Trademark Overview

On Thursday, January 16, 2014, a trademark application was filed for XIENCE ALPINE with the United States Patent and Trademark Office. The USPTO has given the XIENCE ALPINE trademark a serial number of 86167094. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, March 3, 2026. This trademark is owned by Abbott Cardiovascular Systems Inc.. The XIENCE ALPINE trademark is filed in the Medical Instrument Products category with the following description:

Drug-eluting stents
xience alpine

General Information

Serial Number86167094
Word MarkXIENCE ALPINE
Filing DateThursday, January 16, 2014
Status710 - CANCELLED - SECTION 8
Status DateTuesday, March 3, 2026
Registration Number4717729
Registration DateTuesday, April 7, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements

Goods and ServicesDrug-eluting stents

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, March 3, 2026
Primary Code010
First Use Anywhere DateTuesday, September 23, 2014
First Use In Commerce DateTuesday, September 23, 2014

Trademark Owner History

Party NameAbbott Cardiovascular Systems Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
US
Party NameAbbott Cardiovascular Systems Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
US
Party NameAbbott Cardiovascular Systems Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95054
US

Trademark Events

Event DateEvent Description
Monday, January 20, 2014NEW APPLICATION ENTERED
Wednesday, January 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 21, 2014ASSIGNED TO EXAMINER
Wednesday, April 23, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 7, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Tuesday, May 27, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 28, 2014NOTICE OF PUBLICATION
Tuesday, July 22, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 22, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, February 26, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 22, 2015USE AMENDMENT FILED
Thursday, February 26, 2015STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 5, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 6, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 7, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, April 7, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 6, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, January 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 12, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 12, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, April 7, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 4, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, August 18, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 18, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, March 3, 2026CANCELLED SEC. 8 (10-YR)
Tuesday, March 3, 2026NOTICE OF CANCELLATION SEC. 8 EMAILED

Related Keywords

alpine xience stents eluting drug